"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on the U.S. FDA Approval of Fludarabine Phosphate Injection of the Wholly-owned Subsidiary

About this update from Zhejiang Hisun Pharmaceutical Co., Ltd. Class A

Announcement on the U.S. FDA Approval of Fludarabine Phosphate Injection of the Wholly-owned SubsidiaryThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:View Attachment

View stock analysis, news, and events for Zhejiang Hisun Pharmaceutical Co., Ltd. Class A